U.S. Supreme Court Rejects Cases Seeking Workers’ Comp for Medical Cannabis

[ad_1]

The United States Supreme Court on Tuesday denied petitions to hear two cases challenging Minnesota’s refusal to allow coverage for medical cannabis through the state’s workers’ compensation program. In both cases, workers sought a review of the Minnesota Supreme Court’s decision finding that the federal Controlled Substances Act (CSA) supersedes state law, resulting in a denial of coverage for medicinal cannabis for the employees’ work-related injuries.

The Supreme Court invited the U.S. Department of Justice to file a brief in the case before making a decision. In its response, the Justice Department agreed with the Minnesota court that the CSA does preempt state law. But attorneys with the Justice Department also argued that the states have not adequately addressed the issue of federal preeminence and urged the Supreme Court to reserve judgment on evolving law.

The case was not the first time a state court had ruled on workers’ compensation coverage for medical pot. In 2014, the New Mexico Court of Appeals approved the reimbursement of claims for medicinal cannabis for work-related injuries. But rulings on similar cases in Maine, New Hampshire, New Jersey, New York and Minnesota have not been consistent. Courts in New Hampshire, New York, and New Jersey found that state law was not in conflict with the CSA and authorized workers’ compensation claims for medical cannabis. But in Maine, Massachusetts, and Minnesota, judges have ruled that federal law takes precedence.

Is the SCOTUS Decision Bad News?

Attorney Anne Davis, the co-founder of Bennabis Health, a company specializing in affordable medical cannabis access for patients, says that the Supreme Court’s decision to decline to hear the cases is not necessarily a negative outcome for patients.

“While I would’ve loved a decision by the federal government mandating that cannabis is in fact a covered benefit, [the court] deferring to the states could be good in the grand scheme of the industry,” Davis writes in an email to High Times. “The more that the Supreme Court defers to states’ rights, I think the more it helps our growing industry. If the federal government takes the hands-off approach and leaves it to states’ rights, that allows the cannabis industry to grow and expand.”

With states taking the lead on pot reform, Davis believes federal legislation that permits cannabis trade between the states would create the most favorable climate for the industry.

“The problem we’re left to deal with is interstate commerce,” said Davis. “If we can somehow navigate that, then I think state rights having control over the cannabis industry is a much better option than the federal government rescheduling and allowing big Pharma to take control.”

Some advocates for cannabis policy reform had hoped the Supreme Court would weigh in on the Minnesota cases following comments from Justice Clarence Thomas last year indicating he believes the federal prohibition on pot no longer makes sense with so many states passing legislation in conflict with federal law.

“A prohibition on intrastate use or cultivation of marijuana may no longer be necessary or proper to support the federal government’s piecemeal approach,” he wrote.

Unanswered Questions

Commentating on a case the Supreme Court declined to hear in which a Colorado cannabis dispensary challenged federal policy denying standard business deductions for weed companies, Thomas said that a 2005 high court ruling upholding the federal prohibition on cannabis possession may be out of date.

“Federal policies of the past 16 years have greatly undermined its reasoning,” he continued. “The federal government’s current approach is a half-in, half-out regime that simultaneously tolerates and forbids local use of marijuana.”

This week’s action by the U.S. Supreme Court leaves many unanswered questions about the viability of workers’ compensation coverage for medical cannabis. In an analysis of the denial to grant the petitions, The National Law Review wrote that the “Supreme Court’s decision to remain on the sidelines of the debate over marijuana legalization is disappointing to many who were hoping to see the high court help to break the logjam in Congress. The decision also leaves in place the clear conflict over workers’ compensation reimbursement of medical cannabis in state court decisions and facilitates the potential for further conflict as this issue continues to percolate throughout the country.”

[ad_2]

Source link

Why Do People Use Cannabis?

Why Do People Use Cannabis?

[ad_1]

cannabis and wellness and health uses

POLL: 91% OF ADULTS WHO HAVE USED CANNABIS DID SO FOR HEALTH AND WELLNESS PURPOSES

 

The thought that the majority of cannabis users are chronic stoners is one of the greatest misunderstandings that keep on afflicting the cannabis community. Reefer Madness narratives that persist today, even after legalization in many states has proved otherwise. Nevertheless, there is new research dissipating that ill-informed belief. Its biggest discovery is that a massive majority of adults from 21 years of age and older use marijuana for health and wellness reasons.

 

CURALEAF’S SURVEY

 

A new study carried out by Harris Poll in conjunction with Curaleaf Holdings Inc, which is a prominent International manufacturer of consumer cannabis products, discovers that 91% of adults 21 years and above who have ever indulged in marijuana have done it for wellness and health reasons. The results give significant takeaways reflecting the attitude of individuals towards both the preference of holistic wellness and health and cannabis, as 75% of Americans claim that they would rather go for holistic solutions over pharmaceuticals to deal with medical problems when possible, with 62% of people stating that they would rather use marijuana as opposed to pharmaceuticals when dealing with medical problems.

 

From the online survey conducted with close to 2,000 U.S. adults 21 years and older by the independent pollster, the highest wellness and health purposes Americans have used marijuana include; to reduce anxiety (41%), to help with sleep (49%), to reduce stress (49%), and to relax (51%).

 

As marijuana legalization keeps on moving in the U.S., manners and beliefs around the use of the cannabis plant are starting to become more conventional and inclusive for consumers and patients who depend on it for various health and wellness requirements. Common health issues range from aiding with stress relief and insomnia to assisting in reducing arthritis and menstrual cramps.

 

Curaleaf recognizes this transition and growing requirement for marijuana solutions and emphasizes the approachability and accessibility of various products for people who are looking for options for wellness and health requirements. The organization remains a wellness destination having 130 dispensary locations and a variety of marijuana products in several form factors, with an impending wellness line anticipated to kick off later this summer.

 

Clinical Cannabis Pharmacist for Curaleaf New York, Dr.Stacia Woodcock, said informing consumers on how marijuana can be utilized to benefit daily wellness and health requirements is important to reducing the stigma around the plant and giving consumers more options to best match their lifestyle. She added that there are a lot of ways to safely consume cannabis, and a lot of formulations possess little intoxicating effects.  Various choices of products with different ratios of THC and CBD give customers the chance to consume marijuana in a way that suits their lifestyle and level of comfort.

 

The study also discovered that 88% of people who have consumed marijuana in addition to or as an alternative to pharmaceutical treatments believe that doing that has enhanced their overall wellness. As a matter of fact, 86% of people who have used cannabis for wellness or health would suggest it to a family member or a friend for medical purposes.

 

MAJOR USE OF MEDICAL MARIJUANA

 

The most popular ways for medical marijuana to be used include violent or lasting pain, vomiting and nausea due to cancer treatments (chemotherapy), and severe muscle seizures.

 

Pain medicine specialist Barth Wilsey, MD, of the University of California Davis Medical Center, says the primary purpose for which people request a prescription is pain. The pain could be from a disease like cancer, headaches, or a long-term condition, like nerve pain or glaucoma.

 

You can acquire a “marijuana card” if you reside in a state where marijuana for medical use is permitted, and your doctor feels it will benefit you. You’ll be placed on a list that enables you to buy cannabis from a dispensary, which is an approved seller. Physicians may also prescribe medical cannabis to treat  seizure disorders, muscle spasms caused by multiple sclerosis, Crohn’s disease, weight loss, and poor appetite resulting from chronic sicknesses, such as nerve pain or HIV.

 

The Food and Drug Administration has also authorized THC, which is a crucial component in cannabis, to improve appetite and treat nausea. It is accessible by prescription Cesamet (nabilone), which is used to manage vomiting and nausea resulting from the chemotherapeutic agents employed in cancer treatments. Marinol (dronabinol) is used to manage the vomiting and nausea resulting from the chemotherapeutic agents employed for cancer treatment and to promote appetite in patients with AIDS.

 

ADDITIONAL USES

TO EFFECT DRUG AND ALCOHOL ADDICTION

 

Another thorough examination of the evidence, published last year in the publication Clinical Psychology Review, found that cannabis could help individuals who are addicted to opioids or alcohol battle their addiction. Although this discovery may be controversial as the National Academies of Sciences review indicates that the use of cannabis drives a greater danger of becoming dependent on and abusing other substances.

 

Also, the more cannabis a person takes, the more the probability that they have a problem with using it. People who started using cannabis at a young age are also at a higher risk of acquiring a cannabis addiction problem.

 

EFFECT ON DEPRESSION, POST-TRAUMATIC STRESS DISORDER, AND SOCIAL ANXIETY

 

The study published in Clinical Psychology Review evaluated all published scientific books that examined the use of marijuana as a treatment for mental illness symptoms. Their authors discovered some proof backing the use of marijuana to alleviate post-traumatic stress disorder and depression symptoms. Having said that, they warn that marijuana is not an ideal solution for some other mental illnesses, such as psychosis and bipolar disorder.

 

The study suggests that there is some proof that implies marijuana may help with social anxiety symptoms. Still, yet again, this is opposed by the National Academies of Sciences, Engineering, and Medicine study, which instead concluded that chronic marijuana users might be at a higher risk of social anxiety.

 

BOTTOM LINE

Due to the massive stigma that follows cannabis, it is believed that most people who use it are chronic smokers and addicts who want to get high. The result of a survey carried out to that effect, however, proved shocking as it was found that the majority of cannabis users do so for health and wellness purposes as there are a lot of medical benefits that can be gotten from the plant.

 

HEALTH, WELLNESS, CANNABIS, READ MORE…

CANNABIS WELLNESS

IS CANNABIS THE NEW WELLNESS DRUG OF THE MODERN HUMAN?

[ad_2]

Source link

Is Smoking Cannabis Before or After Surgery Safe?

Is Smoking Cannabis Before or After Surgery Safe?

[ad_1]

No matter how minor a procedure, having surgery is an anxiety bomb. Depending on the procedure, you may have a protocol to follow before and afterward, and it may disrupt your regular cannabis smoking, vaping, dabbing, or ingesting routine. 

Cannabis has remained part of our medical repertoire for centuries because, well, it works! In ancient China, Egypt, the Americas, and more, humans have documented weed usage to treat all kinds of maladies. Be sure to only consume products from a safe, lab-tested source, and be honest with your anesthetist and other healthcare providers.

We’ll go into whether you might have to temporarily abstain from weed, or if cannabis can help your healing routine.

What is anesthesia and how does it work?

Put simply, anesthetics is a medical treatment, often composed of more than one form of medication, designed to sedate the patient, relax their body, and prevent them from feeling pain during an operation, surgery, or invasive medical test like a biopsy.  

There are three main forms of anesthesia given to patients before an operation: 

  • Local, in which only the immediate area round the surgical site is numbed and the patient remains conscious
  • Regional, where a broader area is numbed but the patient may still remain conscious (such as for a cesarean section)
  • General, where the patient is entirely sedated and unconscious during the procedure
Male anaesthesiologist hand pointing vital activity data at modern monitor system in operation room. Selective focus.
It’s crucial that the team conducting your operation know about your cannabis use. (Courtesy okrasiuk/Adobe Stock)

These are commonly given to patients, as you may see in shows like Grey’s Anatomy, via an IV injection or gas inhalation with a mask, but topical and transdermal options exist as well.     

Despite its prevalence and necessity in the medical world for over 150 years, we still lack a complete understanding of the nuances of how anesthetics impact our body’s systems and functions. Some research indicates that anesthetics prevent interactions between neurons

Provided there are no underlying allergies to a medication, anesthesia does not impact respiratory or cardiovascular functions.   

Local and regional anesthesia are used more frequently for oral surgeries, cavity fillings, administering stitches to a wound, and epidurals during childbirth. More intense and longer surgeries, such as organ transplants, reconstructions, and emergency removals, require general anesthesia, under which the patient will be unconscious for several hours. These differences impact how cannabis use may interact with the efficacy of your anesthesia plan.

Related

Cannabis for pain: Does medicating with marijuana increase abuse risk?

How does cannabis use affect anesthesia?

Evidence remains scarce, though studies have found that a general anesthesia, propofol, interact with our endocannabinoid systems. Some researchers believe this could lead to cannabinoid-based anesthetics without the risks associated with substances like fentanyl. A British Journal of Pharmacology article indicates propofol may enhance brain endocannabinoid levels, giving it sedative properties, but can’t predict how individuals will fare based on their use.     

A study in the Journal of Osteopathic Medicine found a strong correlation that cannabis users show a higher tolerance to propofol and other forms of anesthesia compared to non- or infrequent users, which can alter how it will affect them during surgery and how much is needed for a successful operation. But due to lack of research studies on humans, it’s unclear how same-day cannabis use influences anesthesia, if at all.

Do I need to stop smoking before surgery?

Surgeon, surgical doctor, anesthetist or anesthesiologist holding patient's hand for health care trust and support in professional ER surgical operation, medical anesthetic safety, healthcare concept
Insufficient research means many health care providers aren’t equipped to discuss cannabis use. (Courtesy Chinnapong/Adobe Stock)

While we do not currently have the breadth of research required to definitely say whether it is safe or not to smoke before surgery, current findings point toward some potential risks that are not necessarily cannabis-related, but pertain to smoking in general. We advise that you speak with your primary care doctor about cannabis use and how it may interact with anesthesia during surgery. 

While smoking cannabis has a myriad of potential benefits, it still involves burning a plant and exposing one’s lungs to carcinogenic material. Anesthesia can potentially impede the body’s air passages and influence blood pressure; long-term damage and irritation from smoking can lead to complications. 

Currently, there are no known documented cases of cannabis use leading to death during surgery.

How long before surgery should one stop smoking cannabis, if necessary?

This is a personal choice that depends on the procedure. For operations where only local anesthesia is involved and the heart and airways are largely unaffected, the risk is lower. For edible lovers, patients should stop ingesting within the same time frame their doctors recommend they should abstain from eating and drinking beforehand. 

Related

Me vs. The Weed: Coming back from a tolerance break

Some experts recommend abstaining from all forms of consumption weeks beforehand out of an abundance of caution, while others, as stated in a 2018 article in research journal Heliyon, recommend stopping smoking at least 72 hours beforehand.

How to talk about marijuana use with healthcare providers

Many medical marijuana patients and recreational consumers alike consider cannabis use a private matter. The last century of US-led cannabis prohibition and the decades of the War on Drugs has unfortunately eroded many people’s trust in the medical establishment to provide them accurate information on cannabis and its potential side effects. 

Given how weed and its compounds can interact with anesthesia during surgery, it is crucial for your health and long-term benefit to disclose your cannabis use to your primary care team. Despite its Schedule I status, disclosing cannabis use to a doctor or healthcare provider falls under the Health Insurance Portability and Accountability Act of 1996 (HIPAA). Under this, cannabis use cannot be used against you or reported to law enforcement unless there is an imminent threat to public safety or your health. Please note that these protections may not extend to minors. 

Doctor hand holding bud of medical cannabis and pills
Cannabis offers patients an alternative to opioids for post-op recovery. (Courtesy eight8/Adobe Stock)

However, doctors can refuse services to patients. And keep in mind that because there is not a lot of concrete research on cannabis, doctors may tell you to abstain from using marijuana because they cannot confirm or deny claims.

But as states continue to expand medical marijuana programs, many have made finding a doctor familiar with cannabis therapy and its impacts on other medications and treatments easier. If you live in a state with medical or adult-use cannabis, the state health department may have resources for finding doctors familiar with cannabis. 

Will cannabis affect anesthesia for heart patients?

Many high profile health organizations, such as the American Heart Association and the CDC, advise against using cannabis to mediate heart-related conditions, and suggest that cannabis use could actually worsen symptoms and vulnerability to heart disease. However, they also state that these beliefs are based on minimal and observational research, as cannabis’ Schedule I status makes it incredibly hard to fund research for and study.

Related

Debunking Dispensary Myths

They also largely refer to smoking cannabis, not other methods such as ingestion. Smoking cannabis can lead to increased heart rate and blood pressure, and research shows that cannabinoids have both vasodilation and vasoconstriction effects in studies on animals; a recent study by scientists at Stanford Medicine concluded that marijuana use has some connection to heart disease, but not enough evidence supports this as a guaranteed outcome of cannabis use.

What’s the best method of consumption before surgery?

If abstaining from cannabis consumption simply isn’t an option, there are various methods that don’t involve smoking or eating. Most surgery protocols require the patient to abstain from eating for a certain number of hours before the operation to prevent complications with anesthesia and digestion. Eating an edible or smoking on an empty stomach will also increase the intensity of cannabis’ effects. 

This doesn’t leave too many options, but a tincture dose or a transdermal product would be safest, as any method that minimizes inhalation and ingestion are ideal.

Is cannabis good as a post-op medicine?

Despite the risks associated with marijuana before surgery, it has many potential benefits for the recovery process. Surgery is invasive and will almost always cause some amount of inflammation at the surgical site. 

Cannabinoids like CBD and CBG have gained popularity for their anti-inflammatory properties, which can simultaneously hasten physical recovery and improve mental well-being. THC remains an acknowledged alternative to opioids for addressing pain, as well as an appetite stimulant, and is good for preventing nausea. 

While your primary care doctor may not be able to prescribe or recommend cannabis as part of your treatment plan, it’s in your best interest to alert them to your usage. Prolonged cannabis use can potentially affect opioid tolerance, which can impact recovery time. Because smoking can cause coughing and irritation in the lungs and throat, we recommend topicals, edibles, and tinctures post-op. A full-spectrum product with both CBD and THC will help the body’s endocannabinoid system more fully engage and you may receive more benefits.

Amelia Williams's Bio Image

Amelia Williams

New York-based freelance cannabis journalist Amelia Williams is a graduate of San Francisco State University’s journalism program, and a former budtender. Williams has contributed to the San Francisco Chronicle’s GreenState, MG Magazine, Culture Magazine, and Cannabis Now, Kirkus Reviews, and The Bold Italic.

View Amelia Williams’s articles

[ad_2]

Source link

Switzerland to Lift Ban on Medical Cannabis

[ad_1]

The Switzerland government announced on June 22 that it will lift the ban on medical cannabis, as according to an amendment to the Swiss Narcotics Act that parliament approved in March 2021. According to Agence France Presse, the government “intends to facilitate access to cannabis for medical use for patients.”

“The decision to use a cannabis-based medicine for therapeutic purposes will rest with the doctor, in consultation with the patient,” the government said of the amendment. As of August 1, patients will no longer be required to obtain permission from the Federal Office of Public Health (FOPH). However, adult-use cannabis sale and consumption will still remain illegal.

In Switzerland, medical cannabis is only allowed for patients with a doctor’s approval, or previously required approval from the FOPH. However, medical cannabis is still only allowed if the medicine contains less than 1% THC, and is licensed. Currently, only Sativex is approved for prescription to patients.

The country’s federal public law institution, Swissmedic, which is responsible for both “authorization and supervision of therapeutic products” including cocaine, methadone, and morphine could eventually be directed to manage the cannabis industry going forward.

Back in 2019, FOPH issued approximately 3,000 authorizations for cannabis patients suffering from a wide variety of medical conditions. However, the FOPH described this process as “tedious administrative procedures.” “Sick people must be able to access these medicines without excessive bureaucracy,” it stated.

In September 2021, the Switzerland government approved a recreational cannabis trial called “Zuri Can,” which is expected to begin this summer. There was one caveat, requiring that only “experienced users” should apply to participate, and this is verified by testing hair samples instead of urine or blood tests. The trial program will be held in Basel, Switzerland, and analyze results from 400 people who will be approved to buy recreational cannabis from specific pharmacies.

Also in June 2022, a new study conducted by the University of Geneva and EBP, a consulting firm, explored the benefits of full cannabis legalization. According to researcher’s findings, approximately 56 tons of cannabis is consumed every year in Switzerland. Based on this data, annual revenue for adult-use cannabis sales could collect up to $582 million Swiss francs (CHF). The industry could generate 0.06% of the country’s economy, which is roughly the same contribution as Appenzell Innerrhoden, the country’s smallest canton by population and area. Legal cannabis could also provide up to 4,400 full time jobs, in comparison to the country’s Swiss accident insurance, which has about 4,200 employees.

Ultimately, as seen in other countries, there are many benefits to establishing a regulatory framework for cannabis legalization. Study author and Research Associate at the Institute of Sociological Research of the University of Geneva Dr. Oliver Hoff explains that it’s time that Swiss cannabis laws received an update. “The simulation shows, that the current form of regulation produces [an] economically inefficient result,” Hoff said in a statement. “While artificially high profit margins enable illegal actors to generate generous profits, consumers suffer from inadequate transparency regarding products and quality. The healthcare system and preventative measures have a hard time accessing consumers with problematic consumption patterns and the state lacks access regarding regulatory, fiscal and public-health oriented initiatives.”

FOPH Head of Policy and Implementation, Adrian Gschwend, also provided a statement about the timing of this study. “The study comes precisely at the right time as the commission for social and healthcare issues of the national assembly has recently started a legislative proposal regarding the legalisation of cannabis,” Gschwend said. “The results show that both the current illicit market as well as a liberal commercial market inflicts costs on the public while individuals generate big profits. We thus need a well-regulated market that ensures both protection for children and adolescents as well as health protection measure.”

[ad_2]

Source link

Got Neuropathy, Try a Cannabis Inhaler For the Best Pain Relief Says New Israeli Study

Got Neuropathy, Try a Cannabis Inhaler For the Best Pain Relief Says New Israeli Study

[ad_1]

neuropathy and cannabis inhalers

Israeli Study Finds That Aerosolized Cannabis Is Beneficial For Neuropathy Patients

 

Neuropathy, also known as nerve damage, can occur from several conditions such as diabetes, cancer, and HIV. It refers to a group of conditions all associated with damaged peripheral nerves and the corresponding symptoms of this issue.

 

The symptoms of neuropathy can vary depending on its cause, though they generally include a permanent or temporary numbness, high sensitivity to touch, prickling or tingling sensations, paralysis, muscle weakness, impairment to sexual function, and many others. Neuropathy may be treatable depending on how severe it is, though treatments are focused on helping nerves regenerate or recover. Depending on the case, neuropathy may be reversible but other times it isn’t, and it can be notoriously difficult and painful to treat. Patients are often left struggling with chronic pain and uncomfortable tingling.

 

However, finding effective treatment is critical because this condition robs people of living a normal life.

 

How Cannabis Can Help

 

There is increasing evidence that cannabis in various forms can be successful in greatly reducing the symptoms of neuropathy. The latest study has been conducted by Israeli researchers in Haifa, who sought out to assess how aerosolized cannabis delivered through a novel selective dose inhaler worked among patients with chronic pain and neuropathy. The patients took an average of 1.5 mg delta 9 THC for several months.

 

The researchers found that this treatment was beneficial in reducing pain while also improving quality of life. “Medical cannabis treatment with the Syqe Inhaler demonstrated overall long-term pain reductions, quality of life improvements, and opioid-sparing effects in a cohort of patients with chronic pain, using just a fraction of the amount of MC [medical cannabis] compared with other modes of delivery by inhalation. These outcomes were accompanied by a lower rate of AEs [adverse events] and almost no AE reports during a long-term steady-state follow-up. Additional follow-ups in a larger population is warranted to corroborate our findings,” the authors concluded.

 

Syqe Medical is an Israeli medical company that is responsible for developing the first selective-dose pharmaceutical-grade inhaler for plant medicine in the world.

 

Another recent study which was published in the Annals of Internal Medicine journal investigated the efficacy of cannabis-related products for chronic pain. Researchers from the Oregon Health and Science University used FDA-approved synthetic cannabis products containing 100% THC: dronabinol and nabilone. They also tested a product called nabiximols, which is a sublingual spray containing equal ratios of THC and CBD, which has had some success in treating neuropathic pain, though it isn’t available in the United States yet.

 

In another study from 2018, published in the American Journal of Neurology, researchers focused on radicular pain, a form of nerve pain that affects the spine and the legs. They also analyzed the impact of THC on radicular pain on a cohort of 15 men suffering from chronic radicular nerve pain. Women were not included in the study since pain sensitivity in females fluctuates around the time of their menstruation. All men reported medium to high pain levels for more than 6 months.

 

They were first given 15mg of THC oil on the first visit, which was taken sublingually while 6 were administered with placebo oil. After a week, they returned for a second visit then those who were given placebo were then given THC, and vice versa. The researchers found that THC was effective in reducing pain when compared with the placebo. Pain levels were rated at 53 on average before taking THC which was reduced to an average of 35 after THC, while those in the placebo rated it at 43.

 

“Pain is a complex experience that involves both the senses and emotions,” explains study’s author Haggai Sharon, MD, of the Tel Aviv Medical Center’s Sagol Brain Institute. “Our study results link pain relief from THC with a reduction in the connections between areas of the brain otherwise heavily connected, suggesting that THC may alleviate pain by disrupting signals between these pain processing pathways.”

 

“Interestingly, our results also show that the more connected the areas of the brain that process emotion and sensory prior to treatment, the greater the pain relief experienced when taking THC,” Sharon explains. “Larger studies are needed to confirm our findings.”

 

Cannabidiol (CBD) may also be beneficial for neuropathy. A 2021 study conducted by Pure Green Pharmaceuticals Inc. analyzed the effect of water-soluble CBD sublingual tablets among diabetic patients who had moderate to severe neuropathic pain. These 54 patients suffered from painful peripheral neuropathy on their feet, and they were randomly given either the Pure Green tablets with 20mg of CBD, or a placebo, which they were to take daily for 28 days.

 

They found that the patients who were given the CBD tablets reported significant reductions in pain levels, compared to the pain group. Additionally, those given CBD also reported improvements in quality of life as well as reductions in anxiety and improvements in sleep quality.

 

“Achieving clinical and statistical pain relief for these patients in just a few weeks is very gratifying and frankly unexpected. Interestingly, the results of this placebo-controlled trial mirrored those of Pure Green Pharmaceuticals’ open-label pDPN trial where both studies revealed a significant drop in pain scores by approximately 50 percent. Patient safety always comes first and was our primary marker. There were no adverse events in either clinical trial to patients on treatment medication,” explained Dr. Debra Kimless, Pure Green’s Chief Medical Officer and a Board-Certified anesthesiologist.

 

“A collaborative drug development meeting with the FDA set us on this path and we look forward to returning to FDA and share this data. FDA is keen to relieve patients suffering in this very large patient population, especially since COVID-19 appears to have increased the number of diabetic patients,” added Stephen Goldner, Pure Green Pharmaceuticals CEO, and an FDA expert.

 

Conclusion

 

With these promising results, patients with neuropathy are encouraged to speak to their doctors on the possibility of adding cannabis products to their treatment plans.

 

WHAT IS A CANNABIS INHALER, READ THIS…

WHAT IS A CANNABIS INHALER

WHAT IS A CANNABIS INHALER AND WHO IS MAKING THEM?

[ad_2]

Source link

Wee-Delivery Chatbox
!

Wee-Delivery Assistant

How can I help you?

Hi there! 👋 Welcome to Wee-Delivery. How can I assist you today?
Call us: 888-422-9658
Hours: Mon-Fri 9am-1pm, closed 2pm-6pm, then open until 11pm. Saturday 9am-11pm, Sunday by appointment.
Delivery minimum
Are you open now?
Service areas
Verification process
Payment methods
After hours
How to order
Call 888-422-9658